<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.8'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//www.biotechreality.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://www.biotechreality.com/2026/08/novo-nordisk-ziltivekimab-zeus-trial.html</loc>
  <lastmod>2026-07-31T20:02:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Novo Nordisk Ziltivekimab ZEUS Trial: Phase 3 Cardiovascular Readout Misses Primary MACE Reduction Target</news:title>
   <news:publication_date>2026-07-31T20:02:42Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.biotechreality.com/2026/07/roche-biocon-perjeta-lawsuit.html</loc>
  <lastmod>2026-07-31T15:10:48Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Roche Biocon Perjeta Lawsuit: Genentech Sues Over Biocon&amp;#039;s Breast-Cancer Biosimilar in New Jersey Court</news:title>
   <news:publication_date>2026-07-31T14:47:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.biotechreality.com/2026/07/sanofi-q2-2026-results.html</loc>
  <lastmod>2026-07-30T19:47:19Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Sanofi Q2 2026 Results: Dupixent Sales Growth Powers Record Second Quarter as Guidance is Upgraded</news:title>
   <news:publication_date>2026-07-30T19:47:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.biotechreality.com/2026/07/iqvia-q2-2026-results.html</loc>
  <lastmod>2026-07-29T19:15:22Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>IQVIA Q2 2026 Results: Revenue Climbs 8.7% to $4.37 Billion, Company Raises Full-Year 2026 Guidance</news:title>
   <news:publication_date>2026-07-29T19:15:19Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.biotechreality.com/2026/07/gsk-q2-2026-results.html</loc>
  <lastmod>2026-07-29T05:09:55Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>GSK Q2 2026 Results: Core Operating Profit Rises 7% as Specialty Medicines and Vaccines Drive Growth</news:title>
   <news:publication_date>2026-07-29T05:09:52Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
